FORESEE PHARMACEUTICALS AND WESTWOOD & WILSHIRE TEAM UP TO HIRE VICE PRESIDENT OF REGULATORY AFFAIRS

Newark, Delaware, May 17— Foresee Pharmaceuticals, a clinical stage drug-device company with multiple filings, has hired Bill Miller as the new Vice President of Regulatory Affairs. Foresee was created as a research division of QPS, a large Taiwanese research organization, and spun off in 2011.

Dr. Miller joins Foresee from Pharmalex, where he was a Senior Director, and before that CSL Behring, where he served as the Global Regulatory Lead. Dr. Miller brings over fifteen years in regulatory affairs as well as a strong background in both 505(b)2 and traditional regulatory pathways to Foresee Pharmaceuticals. He received his PhD from the University of Pennsylvania, Philadelphia.

The search was successfully led by James Reynolds for Westwood & Wilshire’s Life Sciences Practice.

Westwood & Wilshire is a retained executive search firm that recognizes people as any organization’s top asset. The firm has delivered premier talent to many of the world’s most innovative companies in life sciences, healthcare, and advanced technology. Westwood & Wilshire specializes in bringing top-tier candidates at the mid-management to C-Suite level to clients ranging from VC backed start-ups to mid-sized commercial entities. The firm has offices in Los Angeles, Silicon Valley, Scottsdale, and Connecticut serving clients worldwide.